Calculate Embedded Emissions for Unwrought Aluminium (HS7601)

Enter your input

Payable emissions (tCO₂e/t)

Total CBAM Cost (€)

Notes:
There may be a difference when calculating the price with respect to import volume, carbon price, and benchmark emissions, as the embedded formula may result in minor variations due to decimal rounding. Therefore, the actual value may vary.

CBAM is applicable to trade volumes starting from 50 metric tonnes. For trade volumes below 50 metric tonnes, CBAM does not apply.

Usage Procedure – How to use the CBAM Calculator Sheet

Enter or update values only in the INPUT
PARAMETERS section (Highlighted in blue) , including
the carbon price, benchmark emissions, CBAM
chargeable percentage (as per the phase-in year),
and imported quantity.

The system will automatically calculate the payable
emissions and the total CBAM cost (€) based on the
inputs provided.

Notes:
• Change any input value to automatically update CBAM cost.
• Formula used: Carbon price × payable emissions × quantity.
• Model aligned with CBAM supplier-side illustrative methodology.

06 DECEMBER 2021 AL CIRCLE

Fight against COVID, India’s KAISHA Packaging supplies flip-top aluminium seals for two billion doses of vaccines globally

EDITED BY : RUPANKAR MAJUMDER 2MINS READ

The Mumbai, India based pharma-packaging house, KAISHA Packaging has successfully delivered over 2 billion doses worth of flip-top aluminium seals used for packaging COVID vaccines. The aluminium seal is used as a closure for injection vials during the vaccination drive and is one of the vital parts of the vaccine package that ensures tamper-proof delivery.

India’s KAISHA Packaging supplies flip-top aluminium seals for two billion doses of vaccines globally

{alcircleadd}

The premium manufacturer of pharmaceutical closure systems for vials, KAISHA Packaging has been a persistent and largest supplier for these seals to all the vaccines available in the Indian domestic market and overseas. To ensure an unfailing supply of vaccines and corks any shortages or gaps, the company accomplished to line up and stock an enormous volume of raw material.

KAISHA Packaging not only effectively manage this challenge, but also broadened its capacity by over 450 million pieces to attain the overall capacity of 1.2 billion pieces per annum over the previous year, which was ground-breaking.

Rishad Dadachanji, Director of KAISHA Group of Companies stated: “As a pharma allied sector company, we have worked hard to ensure no gaps remain in our supply chain to ensure a consistent supply of vaccine seals. We are proud to have provided seals for over 2 billion vaccine doses so far. Under the current circumstances of ambiguity around the COVID pandemic, Kaisha is well-prepared to rise to any supply challenges.”

Tagged with: